Review and prospect of immune checkpoint blockade therapy represented by PD-1/PD-L1 in the treatment of clear cell renal cell carcinoma

As a common tumor of the urinary system, the morbidity and mortality related to renal carcinoma, are increasing annually. Clear cell renal cell carcinoma (CCRCC) is the most common subtype of renal cell carcinoma, accounting for approximately 75% of the total number of patients with renal cell carci...

Descripción completa

Detalles Bibliográficos
Autores principales: GE, WENFEI, SONG, SHIYAN, QI, XIAOCHEN, CHEN, FENG, CHE, XIANGYU, SUN, YONGHAO, WANG, JIN, LI, XIAOWEI, LIU, NANA, WANG, QIFEI, WU, GUANGZHEN
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tech Science Press 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10229311/
https://www.ncbi.nlm.nih.gov/pubmed/37305384
http://dx.doi.org/10.32604/or.2023.027942

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10229311/
https://www.ncbi.nlm.nih.gov/pubmed/37305384
http://dx.doi.org/10.32604/or.2023.027942

Ejemplares similares